DataMeds AI, Inc. - 8-K Filing

DataMeds AI secures exclusive U.S. license for REBOOT Health AI platform to manage GLP-1 users and issues shares valued at $2 million in the process (Items: 1.01 Entry into a Material Definitive Agreement, 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 3.02 Unregistered Sales of Equity Securities)

SEC EDGAR ·

Tickers: $WGRX

Read the full article at SEC EDGAR

Part of the story DataMeds AI, Inc. - 8-K Filing (3 articles)

More Regulatory news